SOPHiA GENETICS (SOPH) Finished Goods (2020 - 2021)
SOPHiA GENETICS (SOPH) reported Finished Goods of $87000.0 for Q4 2021, down 31.5% on a YoY basis from $127000.0 in Q4 2020, and down 31.5% sequentially from $127000.0 in Q4 2020.
SOPHiA GENETICS (SOPH) Finished Goods (2020 - 2021) Analysis & Trends
SOPHiA GENETICS (SOPH) has 2 years of Finished Goods data on file, last reported at $87000.0 in Q4 2021.
- For the quarter ending Q4 2021, Finished Goods fell 31.5% year-over-year to $87000.0; the trailing twelve-month figure through Dec 2021 stood at $87000.0 (down 31.5% YoY), and the FY2021 full-year result was $87000.0, down 31.5% from the prior year.
- Finished Goods declined to $87000.0 in Q4 2021, from $127000.0 in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $127000.0 in Q4 2020 to a low of $87000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 29.34 Bn | 22.03 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.49 Bn | 12.59 Bn | 482.22 Mn |
| 3 | Healthequity | 7.96 Bn | 7.70 Bn | 256.31 Mn |
| 4 | 10x Genomics | 6.17 Bn | 5.63 Bn | 106.18 Mn |
| 5 | Hinge Health | 6.02 Bn | 5.70 Bn | 154.23 Mn |
| 6 | MiniMed | 4.19 Bn | 3.89 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.14 Bn | 4.07 Bn | 216.84 Mn |
| 8 | Doximity | 3.82 Bn | 3.08 Bn | 125.97 Mn |
| 9 | Privia Health | 3.10 Bn | 2.73 Bn | - |
| 10 | SOPHiA GENETICS | 408.62 Mn | 338.33 Mn | 14.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 87,000.00 |
| Dec 31, 2020 | 127,000.00 |